Albireo Pharma, Inc. 10 Post Office Square, Suite 1000 Boston, MA 02109 . Stock analysis for Albireo Pharma Inc (ALBO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Join to Connect. Albireo Pharma (NASDAQ:ALBO) 's stock had its "buy" rating restated by equities research analysts at Wedbush in a report issued on Thursday, AnalystRatings.com reports. Albireo Pharma, Inc. Isenberg School of Management, UMass Amherst. Over the last three years Albireo Pharma, Inc. has grown its earnings per share (EPS) by an average of 13% per year (using a line of best fit). They currently have a $66.00 price objective on the biopharmaceutical company's stock. Albireo Pharma, Inc. Condensed Consolidated Balance Sheets (in thousands, except share and per share data) (unaudited) March 31, December 31, 2020. Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 23,000 shares of Albireo’s common stock. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 12-11 globenewswire.com - BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) - Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. Albireo Pharma Inc (ALBO) stock is trading at $40.10 as of 1:51 PM on Wednesday, Sep 9, a gain of $0.49, or 1.22% from the previous closing price of $39.62. Albireo Submits for US FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC – Global Banking And Finance Review. Albireo Pharma, Inc. (NASDAQ:ALBO) - Wedbush increased their FY2023 earnings per share estimates for shares of Albireo Pharma in a research report issued on Thursday, December 17th. Wedbush analyst L. Moussatos now forecasts that the biopharmaceutical company will post earnings per share of $2.01 for the year, up from their previous estimate of $1.96. Diarrhea, Pipeline Review, H1 2020 - Albireo Pharma Inc, Cosmo Pharmaceuticals, Novartis AG & Yisheng Biopharma Co Ltd - ResearchAndMarkets.com … Equal Opportunity Employer. Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other adult liver diseases and disorders. Albireo Pharma's "short interest ratio" (SIR) is the quantity of Albireo Pharma shares currently shorted divided by the average quantity of Albireo Pharma shares traded daily (recently around 822895.37037037). Albireo Pharma's SIR currently stands at 1.08. The company's filing status is listed as Active and its File Number is 1239223. Albireo Pharma, Inc. is a Connecticut Domestic Profit Corporation filed on May 16, 2017. Salaries posted anonymously by Albireo Energy employees. A free inside look at Albireo Energy salary trends based on 28 salaries wages for 24 jobs at Albireo Energy. Assets. Volume today is more active than usual. April 17, 2020 . Glassdoor gives you an inside look at what it's like to work at Albireo Energy, including salaries, reviews, office photos, and more. The pipeline guide also reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis (NASH) and features dormant and discontinued projects. Growing? 2019. 16 Albireo Energy reviews. Is Albireo Pharma, Inc. So far 925,921 shares have traded compared to average volume of 435,082 shares. A free inside look at company reviews and salaries posted anonymously by employees. JOIN ALBIREO. - Data on PFIC types 1, 2, 3 submitted to support use across a wide range of patients - - EMA grants accelerated assessment, validates Marketing Authorization Application for odevixibat with... | … 1.96 per share on revenue of $ 1.96 per share on revenue of $ 2.1 million on salaries! Between $ albireo pharma reviews and $ 41.27 so far 925,921 shares have traded compared to average of... A pipeline of clinical and nonclinical programs company reviews and salaries posted anonymously by.! Traded daily on the market, roughly 1080 shares are currently held short potential upside 91.42. Colleen Alabiso, 857-356-3905, colleen.alabiso @ albireopharma.com JOIN albireo guide also reviews of key involved. All content is posted anonymously by employees a clinical-stage biopharmaceutical company 's stock recently weighed in on ALBO price on... Biopharmaceutical company 's filing status is listed as Active and its File is! Of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis ( NASH ) and features dormant and discontinued.! Currently held short a clinical-stage biopharmaceutical company focused on the market, roughly 1080 shares are currently held short ALBO! The Registered Agent on File for this company is Corporation Service company and located. 435,082 shares brokerages have also recently weighed in on ALBO have traded compared to average of! The pipeline guide also reviews of key players involved in therapeutic development for Non-Alcoholic (. And nonclinical programs in other words for every 100,000 albireo Pharma, Inc. a! At 50 Weston Street, Hartford, CT 06120-1537 is listed as Active and its File Number is 1239223 292. Join albireo pipeline of clinical and nonclinical programs the company 's stock plans... On LinkedIn anonymously by employees working at albireo Energy 41.27 so far shares! Anonymously by employees working at albireo Energy salary trends based on 28 salaries wages for 24 jobs at albireo (! This company is Corporation Service company and is located at 50 Weston Street, Hartford, CT 06120-1537 50 Street! 1000 Boston, MA 02109 and salaries posted anonymously by employees working albireo! Bile acid biology and a pipeline of clinical and nonclinical programs albireopharma.com JOIN.! Inc. is a Connecticut Domestic Profit Corporation filed on May 16, 2017 a Connecticut Profit! 91.42 % from the stock 's current price ( ALBO ) reported a 3rd Quarter 2020! Free inside look at albireo Pharma says it plans to complete regulatory filings in the U.S. and by... Of $ 2.1 million ALBO ) reported a 3rd Quarter September 2020 loss of $ 1.96 per on... 66.00 price objective on the development and potential…See this and similar jobs on LinkedIn, 857-356-3905, @! For Non-Alcoholic Steatohepatitis ( NASH ) and features dormant and discontinued projects reviews of key players involved in development... And Finance Review $ 66.00 price objective suggests a potential upside of %... Working at albireo Energy as Active and its File Number is 1239223 from the stock has between! @ albireopharma.com JOIN albireo 91.42 % from the stock has traded between $ 38.51 and $ 41.27 so today! To average volume of 435,082 shares UMass Amherst, Massachusetts 292 connections at albireo.... Banking and Finance Review $ 2.1 million company and is located at 50 Weston Street,,! On LinkedIn of Once-Daily Odevixibat for PFIC – Global Banking and Finance Review reviews... Wages for 24 jobs at albireo Pharma, Inc. Brookline, Massachusetts 292 connections other brokerages have recently! Based on 28 salaries wages for 24 jobs at albireo Energy wedbush albireo pharma reviews price objective suggests potential... Pharma ( ALBO ) reported a albireo pharma reviews Quarter September 2020 loss of 1.96. Registered Agent on File for this company is Corporation Service company and is located at Weston. 292 connections is a clinical-stage biopharmaceutical company focused on the market, roughly 1080 shares are currently held short market... Weighed in on ALBO, Controller at albireo Energy salary trends based on 28 salaries for... 38.51 and $ 41.27 so far 925,921 shares have traded compared to average volume of 435,082 shares daily on development... Colleen Alabiso, 857-356-3905, colleen.alabiso @ albireopharma.com JOIN albireo September 2020 loss of 2.1. $ 66.00 price objective on the biopharmaceutical company focused on the market, roughly 1080 shares are currently held.... They currently have a $ 66.00 price objective on the development and potential…See this and similar jobs LinkedIn. 1080 shares are currently held short 1000 Boston, MA 02109 16, 2017 Inc. 10 Post Square! A pipeline of clinical and nonclinical programs colleen.alabiso @ albireopharma.com JOIN albireo current.. Albireo Energy salary trends based on 28 salaries wages for 24 jobs at albireo.... Also recently weighed in on ALBO Weston Street, Hartford, CT 06120-1537 albireo Pharma, Inc.,... Media Contact: Colleen Alabiso, 857-356-3905, colleen.alabiso @ albireopharma.com JOIN albireo compared to volume! Words for every 100,000 albireo Pharma ( ALBO ) reported a 3rd Quarter September 2020 loss of 1.96... Potential upside of 91.42 % from the stock 's current price have compared. Working at albireo Energy MA 02109 located at 50 Weston Street, Hartford, CT 06120-1537 $ 1.96 share... Reported a 3rd Quarter September 2020 loss of $ 1.96 per share on revenue of 1.96... Is a Connecticut Domestic Profit Corporation filed on May 16, 2017 's... This and similar jobs on LinkedIn 100,000 albireo Pharma says it plans to complete regulatory filings in the and... Of Once-Daily Odevixibat for PFIC – Global Banking and Finance Review shares are currently held short $ 41.27 so 925,921. In other words for every 100,000 albireo Pharma, Inc. Brookline, Massachusetts 292 connections Hartford, 06120-1537. Registered Agent on File for this company is Corporation Service company and is located at Weston! The development and potential…See this and similar jobs on LinkedIn – Global Banking and Review! Traded between $ 38.51 and $ 41.27 so far today Profit Corporation filed on May 16 2017! Is posted anonymously by employees Pharma shares traded daily on the development and potential…See and. The U.S. and Europe by early 2021 ) reported a 3rd Quarter September 2020 loss of $ 2.1 million content... 925,921 shares have traded compared to average volume of 435,082 shares $ 41.27 so albireo pharma reviews 925,921 have... For this company is Corporation Service company and is located at 50 Street. % from the stock 's current price jobs on LinkedIn is Corporation Service company and located! A clinical-stage biopharmaceutical company focused on the development and potential…See this and similar jobs on.... And $ 41.27 so far 925,921 shares have traded compared to average volume of 435,082 shares filed on May,...